Clinical Trials Logo

Spinal Cord Diseases clinical trials

View clinical trials related to Spinal Cord Diseases.

Filter by:
  • Enrolling by invitation  
  • Page 1 ·  Next »

NCT ID: NCT05994846 Enrolling by invitation - Clinical trials for Spinal Cord Injuries

Non-Invasive Electrical and Magnetic Neuromodulation in Persons With Chronic Spinal

RISES-T2
Start date: June 23, 2023
Phase: N/A
Study type: Interventional

The objectives of this study are to (1) determine the effects of neuromodulation techniques on mobility in persons with chronic SCI, as measured by subjective and objective measures, and (2) to determine the optimal combination of techniques that modify mobility and movement in an individual. The neuromodulation techniques explored will be methods of electromagnetic stimulation - that is, electrical stimulation and magnetic stimulation.

NCT ID: NCT05762055 Enrolling by invitation - Clinical trials for Cervical Radiculopathy

Prospective Comparative Analysis of ACDF vs Fusion Interbody Cages With nanoLOCK Osseointegrative Technology

Start date: February 5, 2024
Phase: N/A
Study type: Interventional

Study team will plan a prospective, randomized control trial using our institution's spine clinical outcomes registry. Eligible patients undergoing ACDF (see inclusion criteria listed below) will be randomized to an Intervention or Control Group, which will differ according to the interbody cage used during the procedure. In the Intervention Group (100 patients), Medtronic Titan Endoskeleton TCS zero-profile, stand-alone interbody cages with nanoLOCK osseointegrative technology will be implanted at each treated level. In the Control Group (100 patients), patients will receive an alternative interbody cage system that does not employ nanoLOCK ossteointegrative technology. Interbody cages used in the Control Group (along with the decision to apply anterior plate fixation) will be determined according to surgeon preference. There will be no blinding to the type of implant used. Standard demographic and procedural variables will be collected for all patients (including history of diabetes, tobacco, use, prior use of oral corticosteroids, number of levels fused, and presence of bicortical screw placement). Clinical and radiographic outcomes in the Intervention and Control Groups will be directly compared.

NCT ID: NCT05066711 Enrolling by invitation - Clinical trials for Cervical Radiculopathy

NuVasive® ACP System Study

Start date: May 22, 2022
Phase:
Study type: Observational

The primary objective of this study is to evaluate the safety and performance of anterior cervical spine surgery using the NuVasive anterior cervical plate (ACP) System as measured by reported complications, radiographic outcomes, and patient-reported outcomes (PROs).

NCT ID: NCT04952831 Enrolling by invitation - Clinical trials for Cervical Spondylotic Myelopathy

Diffusion MRI in Cervical Spondylotic Myelopathy

Start date: September 1, 2020
Phase:
Study type: Observational

diffusion MRI in evaluates and predicts prognosis in CSM

NCT ID: NCT04770571 Enrolling by invitation - Clinical trials for Degenerative Disc Disease

Posterior Cervical Fixation Study

Start date: May 10, 2022
Phase:
Study type: Observational

The objective of this study is to evaluate the safety and performance of occipito-cervico-thoracic spine surgery using posterior fixation as measured by reported complications, radiographic outcomes, and patients reported outcomes (PROs).This study is being undertaken to identify possible residual risks and to clarify mid-to long-term clinical performance that may affect the benefit/risk ratio of posterior fixation systems.

NCT ID: NCT04498806 Enrolling by invitation - Cervical Myelopathy Clinical Trials

Activity Monitors as a Measure of Physical Function in Degenerative Cervical Myelopathy

Start date: August 13, 2018
Phase: N/A
Study type: Interventional

The investigators objective of this research is to compare activity monitor results with standard of care (SOC) question-based outcome measures for degenerative cervical myelopathy patients before and after treatment with decompression. Understanding of the relationship between activity monitor data and question-based outcome measures in the context of degenerative cervical myelopathy will improve our understanding of the disease and limit the effort to diagnose and monitor it.

NCT ID: NCT04381663 Enrolling by invitation - Cervical Myelopathy Clinical Trials

CSS-Assessing the Course of Degenerative Cervical Spinal Stenosis Using Functional Outcomes

Start date: September 16, 2019
Phase:
Study type: Observational

The study will consist of two parts: - In Study A, objectively assessed physical activity, gait, balance, range of movement of specific joints during walking and neurophysiological findings between patients with cervical spine stenosis (CSS) without myelopathy who will be treated conservatively and patients with stenosis and signs of myelopathy who are candidates for surgical Treatment will be compared. - In Study B, the 6-month changes in the same outcomes in patients treated conservatively (from the first specialist consultation until 6 months later) and in patients treated surgically (preoperative day and 6-month post-operatively) will be quantified.

NCT ID: NCT04101916 Enrolling by invitation - Clinical trials for Spinal Cord Injuries

PAS in Subacute SCI

Start date: October 10, 2019
Phase: N/A
Study type: Interventional

The investigators have recently shown in incomplete SCI patients that long-term paired associative stimulation is capable of restoring voluntary control over some paralyzed muscles and enhancing motor output in the weak muscles. In this study, the investigators will administer long-term paired associative stimulation to patients with incomplete cervical level SCI at the subacute stage, and investigate its effectiveness for upper extremity rehabilitation.

NCT ID: NCT03513679 Enrolling by invitation - Clinical trials for Cervical Spondylotic Myelopathy

Gait in Adult Patients With Cervical Spondylotic Myelopathy

Start date: March 22, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of cervical decompression surgery on the biomechanics of the lower extremities and spine during balance and gait in patients with cervical spondylotic myelopathy (CSM), before and after surgical intervention, and compare these parameters to an asymptomatic control group. To test our hypothesis that cervical decompression will improve preexisting gait disturbance, a gait analysis using dynamic surface EMG, video motion capture, and force plate analysis will be used. Patients 30 to 70 years old will be eligible for the study. Thirty subjects diagnosed with symptomatic CSM and are deemed appropriate surgical candidates, along with 30 healthy subjects with no spine pathology, will be enrolled in this study. Exclusion criteria include any history of previous lumbar/thoracic surgery or lower extremity surgery, BMI greater than 35, or currently pregnant. Each subject from the surgical group will be evaluated on 3 different occasions: 1) 1 week before surgery, 2) 3 months postoperative, and 3) 12 months postoperative. Control subject will only be evaluated once. Bilateral trunk and lower extremity neuromuscular activity will be measured during a full gait cycle using dynamic surface EMG measurements. Human video motion capture cameras will collect lumbar spine and lower and upper extremity joint angles. Ground reaction forces (GRFs) will be collected from a 5 foot stretch of force platforms in order to define a full gait cycle.

NCT ID: NCT03225625 Enrolling by invitation - Clinical trials for Spinal Cord Injuries

Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study

SciExVR
Start date: July 1, 2017
Phase: N/A
Study type: Interventional

The SciExVR study will evaluate the potential benefit of autologous bone marrow derived stem cells (BMSC) in the treatment of spinal cord injury with evidence of impaired motor or sensory function. The treatment consists of bilateral paraspinal injections of the BMSC at the level of the injury as well as superior and inferior to that spinal segment followed by an intravenous injection and intranasal placement. Patients undergoing BMSC treatment may also be assigned to use of exoskeletal movement (or equivalent) or virtual reality visualization (or equivalent) to augment upper motor neuron firing and/or receptivity of the sensory neurons. http://mdstemcells.com/sciexvr/